| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 02/12/2004 | CA2493253A1 Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy |
| 02/12/2004 | CA2492830A1 Pyrrolidine derivatives as tryptase inhibitors |
| 02/12/2004 | CA2491366A1 Improved transdermal delivery system for the administration of rotigotine |
| 02/11/2004 | EP1388537A1 Arginine derivatives |
| 02/11/2004 | EP1388534A2 2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptors |
| 02/11/2004 | EP1388352A1 Use of a ppar-alpha agonist to treat patients suffering from weight gain associated with a ppar-gamma agonist treatment |
| 02/11/2004 | EP1388344A1 Composition comprising Salvia Miltiorrhizae, Ginseng, Borneol for treating heart disease, and cerebrovascular diseases |
| 02/11/2004 | EP1388341A1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
| 02/11/2004 | EP1388340A1 Compositions for transmucosal administration containing coenzyme q as the active ingredient |
| 02/11/2004 | EP1388283A1 Nonhuman model animal of oligodendrocyte development disability |
| 02/11/2004 | EP1387895A2 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
| 02/11/2004 | EP1387888A2 Nucleic acid-associated proteins |
| 02/11/2004 | EP1387886A2 Proteases |
| 02/11/2004 | EP1387854A2 Sfrp and peptide motifs that interact with sfrp and methods of their use |
| 02/11/2004 | EP1387842A1 Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors |
| 02/11/2004 | EP1387841A1 Novel azole or triazole derivatives, method for preparing same and use thereof as fungicides |
| 02/11/2004 | EP1387840A1 3,5-diamino-1,2,4-triazoles as kinase inhibitors |
| 02/11/2004 | EP1387836A1 Phthalazine derivatives with angiogenesis inhibiting activity |
| 02/11/2004 | EP1387830A1 Novel 4-anilinoquinoline-3-carboxamides |
| 02/11/2004 | EP1387826A1 Novel 5-phenyl-1h-indole derivatives as antagonists of interleukine-8 receptors |
| 02/11/2004 | EP1387825A1 Thyroid hormone receptor antagonists for cardiac & metabolic disorders ii |
| 02/11/2004 | EP1387821A2 Estrogen receptor modulators |
| 02/11/2004 | EP1387706A1 Process and apparatus for utilization of in vivo extracted plasma with tissue engineering devices, bioreactors, artificial organs, and cell therapy applications |
| 02/11/2004 | EP1387698A2 Method of preventing cell death using antibodies to neural thread proteins |
| 02/11/2004 | EP1387694A2 Composition and method for treating cancer using herpes virus |
| 02/11/2004 | EP1387689A1 Combination of a gelatinase inhibitor and an anti-tumor agent, and uses thereof |
| 02/11/2004 | EP1387688A2 Benzazepinone alpha v integrin receptor antagonists |
| 02/11/2004 | EP1387686A1 Timing and duration of administration of adenosine a1/a2 agonist for cardioprotection |
| 02/11/2004 | EP1387685A1 Analgesic composition and method |
| 02/11/2004 | EP1387684A1 Compositions comprising lopinavir and methods for enhancing the bioavailability of pharmaceutical agents |
| 02/11/2004 | EP1387680A1 Benzimidazole derivatives as therapeutic agents |
| 02/11/2004 | EP1387679A1 Sulfonamides |
| 02/11/2004 | EP1387676A2 Compositions comprising an anti-microtubule agent and a polypeptide or a polysaccharide and the use thereof for the preparation of a medicament for the treatment of inflammatory conditions |
| 02/11/2004 | EP1387674A2 Hedgehog antagonists, methods and uses related thereto |
| 02/11/2004 | EP1299356B1 Novel compounds |
| 02/11/2004 | EP1289544B1 Method for treating a movement disorder |
| 02/11/2004 | EP1235569B1 Medicament and combination of compatible medicaments |
| 02/11/2004 | EP1224177B1 Process for preparing oxazolines from tetrahydrofurans |
| 02/11/2004 | EP1216239B1 Piperazine derivatives as 5-ht1b antagonists |
| 02/11/2004 | EP1165491B1 Lta4 hydrolase inhibitors |
| 02/11/2004 | EP1157998B1 Heterocyclic compounds, intermediates thereof and elastase inhibitors |
| 02/11/2004 | EP1144393B1 Benzoxazole derivatives for use as integrin inhibitors |
| 02/11/2004 | EP1069902B1 Use of phospholipids for the manufacture of a medicament for the prevention of adhesions |
| 02/11/2004 | EP1042300B1 Phthalazine derivatives useful as phosphodiesterase 4 inhibitors |
| 02/11/2004 | EP1032561B1 Substituted oximes as neurokinin antagonists |
| 02/11/2004 | EP1011712B1 Combination of cytokines having neurotrophic activity |
| 02/11/2004 | EP1003373B1 Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds |
| 02/11/2004 | EP0936912B1 Inhibitors of cysteine protease |
| 02/11/2004 | EP0909177B1 Aqueous formulations of peptides |
| 02/11/2004 | EP0888452B1 Human cyr61, an extracellular matrix signalling molecule |
| 02/11/2004 | EP0858467B1 Materials and methods relating to the identification and sequencing of the brca2 cancer susceptibility gene and uses thereof |
| 02/11/2004 | EP0832094B1 Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (nhe), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the nhe-inhibitory efficacy of compounds |
| 02/11/2004 | CN1474871A Inhibitor proteins |
| 02/11/2004 | CN1474821A New cephalotaxanes, their method of preapartion and their use in treatment of cancers, leukemias, parasites including thus resistant to usual chemotherapentic agents and reversal agents |
| 02/11/2004 | CN1474820A Benzodiazepine derivatives as GABA A receptor modulators |
| 02/11/2004 | CN1474819A Novel imidazole derivatives, production method thereof and use thereof |
| 02/11/2004 | CN1474816A 4-amino-quinazolines |
| 02/11/2004 | CN1474815A 4-amino-quinazolines |
| 02/11/2004 | CN1474812A (Dihydro) isoquinoline derivatives as phosphodiesterase inhibitor |
| 02/11/2004 | CN1474810A Substituted urea neuropeptide YY5 antagonists |
| 02/11/2004 | CN1474809A Cyanopyrolidine derivatives |
| 02/11/2004 | CN1474805A 2-amino-2-alkyl-5-heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/11/2004 | CN1474703A Taxoid conjugates as antimitotic and antitumor agents |
| 02/11/2004 | CN1474696A Novel pharmacentical compositions with anti-diabetic activity and method for preparing same |
| 02/11/2004 | CN1474690A Synergestic combinations comprising renin inhibitor for cardiovascular diseases |
| 02/11/2004 | CN1474689A CDC25 phosphatase inhibitors |
| 02/11/2004 | CN1474688A Novel uses of combined selective dopamine D2 receptor antagonists and 5-HT1A receptor agonists |
| 02/11/2004 | CN1473589A Fat reducing anti-senility health article |
| 02/11/2004 | CN1473573A 远红外多功能材料 Far-infrared multifunctional materials |
| 02/11/2004 | CN1137898C Analogs of parathyroid hormone |
| 02/11/2004 | CN1137889C Novel tricycloacylamide compound, its preparation method and medicinal composition containing them |
| 02/11/2004 | CN1137888C Inhibitor of cysteninyl aspartic acid proteinase |
| 02/11/2004 | CN1137886C Novel 2,3-dioxo-1,2,3,4-tetrahydro-quinoyxalinyl derivatives |
| 02/11/2004 | CN1137884C Indazole compounds and pharmaceutical compositions for inhibiting protein kinases and methods for their use |
| 02/11/2004 | CN1137883C Aromatic carboxylic acid ester, its production and use of same as medicaments |
| 02/11/2004 | CN1137723C Enhanced wound coverage and composition to enhance wound healing |
| 02/11/2004 | CN1137712C Quick-action oral liquid for treating sprain and pull and its preparing method |
| 02/11/2004 | CN1137688C Methods and compositions useful in prophylaxis and therapy of endotoxin related conditions |
| 02/11/2004 | CN1137680C Aerosol compositions |
| 02/10/2004 | US6689938 Administering an antagonist of melanocortin stimulating hormone (msh) biological activity. |
| 02/10/2004 | US6689909 Substituted N-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity |
| 02/10/2004 | US6689906 Bicyclic amino acids as pharmaceutical agents |
| 02/10/2004 | US6689886 Treatment of inflammation and other immune disorders |
| 02/10/2004 | US6689869 Labeled humanized anti-CD18 antibodies and fragments and kits comprising same |
| 02/10/2004 | US6689816 Treatment of posttraumatic stress disorder, obsessive-compulsive disorder and related neuropsychiatric disorders |
| 02/10/2004 | US6689812 Can be administered with conventional drugs to treat psychiatric or central nervous disorders to improve their efficacy or reduce their side effects |
| 02/10/2004 | US6689804 Imidazo-imidazole |
| 02/10/2004 | US6689794 Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 02/10/2004 | US6689790 Substituted triazolopyridine compounds |
| 02/10/2004 | US6689787 Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia |
| 02/10/2004 | US6689786 Sulfonylurea, sulfonylthiourea, sulfonylguanidine, sulfonylcyanoguanidine and acylsulfonamide derivatives; antithrombotics |
| 02/10/2004 | US6689784 Controlling cell apoptosis |
| 02/10/2004 | US6689778 2-phenylamino-5-isoxazo-4-yl-pyrimidine derivatives |
| 02/10/2004 | US6689771 Amide derivatives as inhibitors of matrix metalloproteinases, TNF-α, and aggrecanase |
| 02/10/2004 | US6689769 Bactericides |
| 02/10/2004 | US6689761 Compound j, nucleoside analog hiv reverse transcriptase inhibitor 3tc and azt |
| 02/10/2004 | US6689758 Treating wounds; using an early growth response-1 transcription factor polypeptide or fragment |
| 02/10/2004 | US6689741 Biocompatible polymers, process for their preparation and compositions containing them |
| 02/10/2004 | US6689580 Growth factor |
| 02/10/2004 | US6689562 Mammalian IAP gene family, primers, probes and detection methods |